Skip to content

Comprehensive intervention technology and product development for sarcopenia in the elderly

Comprehensive intervention technology and product development for sarcopenia in the elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098777
Enrollment
Unknown
Registered
2025-03-13
Start date
2023-06-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

treatment gruoup 1:Patients with normal swallowing, digestion, and liver and kidney function evaluations: whole nutrients powder and protein powder component or single use mushroom protein powder com
treatment gruoup 2:Patients with only swallowing function abnormalities: whole nutrients powder and supplemented with 600IU of vitamin D
treatment gruoup 3:Patients with only digestive/absorption disorders: whole nutrients powder and protein powder or small molecule peptide functional components, 600IU of vitamin D
treatment gruoup 4:Patients only with mild to moderate liver function or kidney function damage: whole nutrients powder, amino acid components, and polysaccharide functional components, supplemented w

Sponsors

Peking Union Medical College Hospital, China Academic Medical Science and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with sarcopenia aged 60 years and above (according to AWGS2019 standards, ASMI males= 12s) 2. Existence or absence of swallowing, digestion and absorption, and liver and kidney dysfunction 3. Sign informed consent form, be able to adhere to dietary and exercise plans, and undergo regular check ups

Exclusion criteria

Exclusion criteria: 1. There are various factors that affect body composition detection, such as metal or pacemaker implantation in the body, disability and inability to stand upright 2. No serious cardiovascular or cerebrovascular diseases 3. Allergies to nutritional ingredients used in research (such as mushroom protein, whey protein, soy protein, etc.) 4. There are other situations where one cannot participate in this study

Design outcomes

Primary

MeasureTime frame
appendicular skeletal muscle mass ;Grip strength;6m walking speed;5 sit up time;

Secondary

MeasureTime frame
Body Weight;Liver Function;Calf circumference;renal function;routine blood test;routine urine test;waist circumference;hip circumference;albumin;prealbumin;25 hydroxyvitamin d;

Countries

China

Contacts

Public ContactMa Fang

Peking Union Medical College Hospital, China Academic Medical Science and Peking Union Medical College

mafang219@126.com+86 139 0115 0181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026